This metabolite features a PDE selectivity profile much like sildenafil and an in vitro potency for PDE5 about 50% from the father or mother drug. Plasma concentrations of this metabolite are approximately forty% of Those people found for sildenafil, so that the metabolite accounts for approximately twenty% of sildenafil’s pharmacologic outcomes.… Read More